We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 415 results
  1. Chronic pregabalin treatment protects against spreading depolarization and alters hippocampal synaptic characteristics in a model of familial hemiplegic migraine-type 1

    Familial hemiplegic migraine type-1 (FHM-1) is a form of migraine with aura caused by mutations in the P/Q-type (Cav2.1) voltage-gated calcium...

    Stuart M. Cain, Sascha R. A. Alles, ... Terrance P. Snutch in Molecular Brain
    Article Open access 03 November 2023
  2. Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes

    Hemiplegic migraine (HM) is a rare subtype of migraine with aura. Given that causal missense mutations in the voltage-gated calcium channel α1A...

    Neven Maksemous, Aster V. E. Harder, ... Lyn R. Griffiths in Molecular Neurobiology
    Article Open access 14 February 2023
  3. Astrocytic Glutamate Transporters and Migraine

    Glutamate levels and lifetime in the brain extracellular space are dinamically regulated by a family of Na + - and K + -dependent glutamate transporters,...

    Fiorenzo Conti, Daniela Pietrobon in Neurochemical Research
    Article 30 December 2022
  4. Migraine

    Migraine is a common, disabling disorder in the central nervous system. Migraine is a disorder that has three key features: the tendency is largely...
    Peter J. Goadsby in Neuroscience in the 21st Century
    Reference work entry 2022
  5. The de novo CACNA1A pathogenic variant Y1384C associated with hemiplegic migraine, early onset cerebellar atrophy and developmental delay leads to a loss of Cav2.1 channel function

    CACNA1A pathogenic variants have been linked to several neurological disorders including familial hemiplegic migraine and cerebellar conditions. More...

    Maria A. Gandini, Ivana A. Souza, ... Gerald W. Zamponi in Molecular Brain
    Article Open access 08 February 2021
  6. Oxidative Stress and Migraine

    The pathogenesis of migraine is not completely understood, but inflammation and oxidative stress seem to be involved, according to data from an...

    Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, ... José A. G. Agúndez in Molecular Neurobiology
    Article 18 March 2024
  7. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents

    Migraine is a debilitating disorder affecting females more frequently than males. There is some evidence that drugs targeting glutamate receptors:...

    Karolina Podkowa, Kamil Czarnacki, ... Justyna Paprocka in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 04 March 2023
  8. Current Update on Categorization of Migraine Subtypes on the Basis of Genetic Variation: a Systematic Review

    Migraine is a complex neurovascular disorder that is characterized by severe behavioral, sensory, visual, and/or auditory symptoms. It has been...

    Kashish Goel, Aakash Chhetri, ... Anjana Munshi in Molecular Neurobiology
    Article 22 December 2023
  9. Role of Omics in Migraine Research and Management: A Narrative Review

    Migraine is a neurological disorder defined by episodic attacks of chronic pain associated with nausea, photophobia, and phonophobia. It is known to...

    Pragya Chaturvedi, Rahul Khan, ... Anjana Munshi in Molecular Neurobiology
    Article 07 July 2022
  10. Glia Signaling and Brain Microenvironment in Migraine

    Migraine is a complicated neurological disorder affecting 6% of men and 18% of women worldwide. Various mechanisms, including neuroinflammation,...

    Hanieh Amani, Alireza Soltani Khaboushan, ... Abbas Tafakhori in Molecular Neurobiology
    Article 30 March 2023
  11. Glutamate in Migraine Neurobiology and Treatment

    Migraine is a disabling chronic condition characterised by recurrent episodes of head pain accompanied by other sensory disturbances. Its...
    Chapter 2022
  12. Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura

    Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association...

    Gyda Bjornsdottir, Mona A. Chalmer, ... Kari Stefansson in Nature Genetics
    Article Open access 26 October 2023
  13. Epilepsy and Migraine Shared Genetic and Molecular Mechanisms: Focus on Therapeutic Strategies

    Epilepsy and migraine are both episodic disorders and share clinical as well as pathophysiological mechanisms. The prevalence of epilepsy in migraine...

    Palvi Gotra, Nidhi Bhardwaj, ... Anjana Munshi in Molecular Neurobiology
    Article 15 April 2021
  14. Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions

    We report a 52-year-old woman presenting with autosomal dominant progressive cerebellar ataxia and familial hemiplegic migraine type 1 whose genetic...

    Kevin R. Duque, Luca Marsili, ... Marcelo A. Kauffman in The Cerebellum
    Article 05 September 2020
  15. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation — a Therapeutic Perspective in Migraine?

    Persistent reprogramming of epigenetic pattern leads to changes in gene expression observed in many neurological disorders. Transient receptor...

    Michal Fila, Elzbieta Pawlowska, ... Janusz Blasiak in Molecular Neurobiology
    Article Open access 16 June 2023
  16. Integrating eQTL and GWAS data characterises established and identifies novel migraine risk loci

    Migraine—a painful, throbbing headache disorder—is the most common complex brain disorder, yet its molecular mechanisms remain unclear. Genome-wide...

    Ammarah Ghaffar, Dale R. Nyholt in Human Genetics
    Article Open access 28 May 2023
  17. Botulinum Toxin Treatment in Migraine and Other Headaches

    Prospective, double-blind and placebo-controlled studies (PREEMPT) have demonstrated the efficacy of onabotulinumtoxinA (onaA) in chronic migraine...
    Chapter 2022
  18. A review of migraine genetics: gathering genomic and transcriptomic factors

    Migraine is a common and complex neurologic disorder that affects approximately 15–18% of the general population. Although the cause of migraine is...

    Andreia Dias, Tiago Mariz, ... Miguel Alves-Ferreira in Human Genetics
    Article 22 October 2021
  19. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

    Migraine affects over a billion individuals worldwide but its genetic underpinning remains largely unknown. Here, we performed a genome-wide...

    Heidi Hautakangas, Bendik S. Winsvold, ... Matti Pirinen in Nature Genetics
    Article Open access 03 February 2022
Did you find what you were looking for? Share feedback.